FdaApplication
NDA 206426
Identifiers
- fda_app_no: NDA206426
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCRYST PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2014-12-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RAPIVAB | PERAMIVIR | 200MG/20ML (10MG/ML) | SOLUTION;INTRAVENOUS |
1 product